Psilocybin Trials: Controlled-Substance Regulatory Roadmap Case Study
A caregiver’s call sparked a controlled-substance roadmap for psilocybin trials. This story-driven case study shows how sponsors balanced ICH E6(R3) guidance, inspection readiness, AI-assisted submissions, and timeline optimization to keep families at the center.
Robert Maxwell
Sep 26, 2025
breast cancer regulation
Stroke device oversight
Parkinson's trial design
diabetic macular edema
